Surface Logix Inc is developing a product pipeline using our Pharmacomer™ Technology Platform to create New Chemical Entities (NCEs) with improved Pharmacokinetic (PK) and or Pharmacodynamic (PD) properties that address:

  • Multiple therapeutic areas
  • High unmet medical needs
  • Significant commercial opportunities

To learn more about a particular indication, please select a particular program.

 
 
   

 

 
 
   
<script language="javascr